• [email protected]
  • +971 507 888 742
Submit Manuscript
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 11 (3), 2015
  3. 248-252
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2015 | Volume: 11 | Issue: 3 | Page No.: 248-252
DOI: 10.3923/ijp.2015.248.252

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 74

Authors


Mi-Ae Kang


See-Hyoung Park


Keywords


  • Anti-rheumatoid arthritis
  • collagen-induced arthritis
  • rosmarinic acid
Short Communication

Development of the Potent Anti-Rheumatoid Arthritis Compound Derived from Rosmarinic Acid and the Evaluation of the Activity in Collagen-Induced Arthritis Mouse Model

Mi-Ae Kang and See-Hyoung Park
Lck, one of the Src family protein tyrosine kinases, plays a critical role in T-cell receptor-induced signaling that leads to T-cell activation, proliferation and differentiation. Interruption of the molecular interaction through the lck SH2 domain blocks T-cell activation and subsequent proliferation. Previously, we demonstrated that rosmarinic acid (RosA), an lck SH2 domain inhibitor, suppresses T-cell function via dual mechanism such as inhibition of T-cell activation and lck-dependent apoptosis induction. RosA alleviated arthritis in Collagen-Induced Arthritis (CIA) model but a fairly high amount of RosA was required. To overcome this problem, we generated various kinds of C-terminus modified RosA analogues and found a methyl ester derivative of RosA (RosA-Me) to have the most improved inhibition activity in IL-2 promoter analysis and T-cell proliferation assay. The objective of this study was to assess the anti-arthritic activity of RosA-Me compared to the parent compound RosA and Methotrexate (MTX) in a murine CIA model. Compared to vehicle, treatment of mice with RosA-Me (50 mg kg‾1 day‾1, i.p.) greatly reduced the inflammation indexes which suggests RosA-Me has better in vivo anti-rheumatoid arthritis activity acquired maybe from the stronger cell penetrating ability. Thus, our studies suggest that RosA-Me is a RosA derivative with a potent anti-arthritic effect in CIA, through its combined immunosuppressive and anti-inflammatory actions.
PDF Fulltext XML References Citation

How to cite this article

Mi-Ae Kang and See-Hyoung Park, 2015. Development of the Potent Anti-Rheumatoid Arthritis Compound Derived from Rosmarinic Acid and the Evaluation of the Activity in Collagen-Induced Arthritis Mouse Model. International Journal of Pharmacology, 11: 248-252.

DOI: 10.3923/ijp.2015.248.252

URL: https://scialert.net/abstract/?doi=ijp.2015.248.252

Leave a Reply


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved